Released Jan 23, 2025, after the close
10-K filed Jan 31, 2025, 31 days after period end · 0001035267-25-000017
Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.41B$2.41B derived+25.2% vs Q4 2023+18.4% vs Q3 2024
Net Income$685.70M$685.70M derived+13.1% vs Q4 2023+21.3% vs Q3 2024
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$1,642,200,000+28.6%
Operating Incomederived$734,900,000+63.2%
Operating Cash Flowderived$822,600,000+260.3%
Free Cash Flowderived$510,600,000N/M
Margins · derived
Gross margin68.0%+1.8 pt vs Q4 2023
Operating margin30.4%+7.1 pt vs Q4 2023
Net margin28.4%−3.0 pt vs Q4 2023
What the release said
The release
Same quarter
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 |
|---|---|---|---|---|
| Revenue | $2.41B | $1.93B | $1.66B | $1.55B |
| Net Income | $685.70M | $606.20M | $324.90M | $380.60M |
| EPS Diluted | — | — | — | $1.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intuitive Surgical Inc · CIK 1035267 · Engraved from SEC EDGAR